Published in Cancer Weekly, September 22nd, 1997
Such testing would improve the identification and early treatment rate of patients who are at high risk for CMV pneumonia after bone marrow transplant (BMT), said A. Ibrahim, Institut Gustave Roussy, Villejuif, France, and colleagues ("Should Cytomegalovirus Be Tested for in Both Blood and Bronchoalveolar Lavage Fluid of Patients at a High Risk of CMV Pneumonia after Bone Marrow Transplantation'", British Journal of Haematology, 1997;98:222-227).
CMV is the primary infection...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.